Challenges experienced during pharmacy automation and robotics implementation in JCI accredited hospital in the Arabian Gulf area: FMEA analysis-qualitative approach.
Failure mode and effects analysis
Medication errors
Performance Improvement Project
Pharmacy automation
Quality Improvement
Risk Management
Robotics
Journal
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
15
02
2023
accepted:
26
07
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
Pharmacy automation and robotics implementation are essential aspects of healthcare facilities. It streamlines the medication dispensing process and significantly reduces medication errors. However, implementing automation and robotics in pharmacies comes with its challenges. We aim to detect and rectify potential dangers in the pharmacy workflow by utilizing the Failure Mode and Effects Analysis (FMEA) methodology; this is expected to augment performance and increase profitability. In this study, we conducted an FMEA analysis using a qualitative approach to identify the challenges experienced during pharmacy automation and robotics implementation in a Joint Commission International (JCI) accredited hospital in the Arabian Gulf area. The pharmacy processes and procedures were mapped in a Flow chart to visualize the pharmacy workflow, including highlighting the risks that were found. Then these risks were arranged as Potential failure modes and added to the table as 9 main points for each RPNs were calculated, and then the 9 points were prioritized for the action plans. Via applying traditional Risk Priority Number (RPN) FMEA, the Pharmacy board identified the process stages marked risky failure modes through several FMEAs, calculating the total RPNs at the implementation phase. It revealed several challenges, including staff training, technical issues, and inadequate communication. Furthermore, the study resulted in corrective and intervention steps. Pharmacy automation and robotics implementation is a complex process that requires proper planning, preparation, and execution. The FMEA approach effectively identifies potential problems and evaluates their impact on the pharmacy system. Nine major failure modes appeared to be risky stages with high RPN scores. Therefore, multiple interventions were done during the implementation to enhance the knowledge of challenges faced during the implementation of the automation process and solve it. Future studies should address the identified challenges and develop strategies to mitigate them.
Sections du résumé
Background
UNASSIGNED
Pharmacy automation and robotics implementation are essential aspects of healthcare facilities. It streamlines the medication dispensing process and significantly reduces medication errors. However, implementing automation and robotics in pharmacies comes with its challenges. We aim to detect and rectify potential dangers in the pharmacy workflow by utilizing the Failure Mode and Effects Analysis (FMEA) methodology; this is expected to augment performance and increase profitability.
Materials and methods
UNASSIGNED
In this study, we conducted an FMEA analysis using a qualitative approach to identify the challenges experienced during pharmacy automation and robotics implementation in a Joint Commission International (JCI) accredited hospital in the Arabian Gulf area. The pharmacy processes and procedures were mapped in a Flow chart to visualize the pharmacy workflow, including highlighting the risks that were found. Then these risks were arranged as Potential failure modes and added to the table as 9 main points for each RPNs were calculated, and then the 9 points were prioritized for the action plans.
Results
UNASSIGNED
Via applying traditional Risk Priority Number (RPN) FMEA, the Pharmacy board identified the process stages marked risky failure modes through several FMEAs, calculating the total RPNs at the implementation phase. It revealed several challenges, including staff training, technical issues, and inadequate communication. Furthermore, the study resulted in corrective and intervention steps.
Conclusion
UNASSIGNED
Pharmacy automation and robotics implementation is a complex process that requires proper planning, preparation, and execution. The FMEA approach effectively identifies potential problems and evaluates their impact on the pharmacy system. Nine major failure modes appeared to be risky stages with high RPN scores. Therefore, multiple interventions were done during the implementation to enhance the knowledge of challenges faced during the implementation of the automation process and solve it. Future studies should address the identified challenges and develop strategies to mitigate them.
Identifiants
pubmed: 37638225
doi: 10.1016/j.jsps.2023.101725
pii: S1319-0164(23)00220-7
pmc: PMC10458704
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101725Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Eur J Hosp Pharm. 2019 May;26(3):157-162
pubmed: 31428324
Entropy (Basel). 2020 Jun 20;22(6):
pubmed: 33286463
Br J Anaesth. 2020 Oct;125(4):425-429
pubmed: 32682551
PLoS One. 2021 Jun 23;16(6):e0253588
pubmed: 34161388
J Eval Clin Pract. 2019 Feb;25(1):28-35
pubmed: 30136339
Eur J Hosp Pharm. 2020 Sep;27(5):253-262
pubmed: 32839256
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1738-1746
pubmed: 29915131
Am J Health Syst Pharm. 2022 May 6;79(10):711-712
pubmed: 35255122
J Patient Saf. 2023 Mar 1;19(2):117-127
pubmed: 36170519
Am J Health Syst Pharm. 2019 Sep 3;76(18):1372-1373
pubmed: 31388675
J Patient Saf. 2022 Apr 1;18(3):201-209
pubmed: 35026796
Hum Factors. 2023 Aug;65(5):766-778
pubmed: 33788594
J Eval Clin Pract. 2020 Aug;26(4):1320-1337
pubmed: 31849153
Entropy (Basel). 2023 May 15;25(5):
pubmed: 37238555
Am J Med Qual. 2022 Nov-Dec 01;37(6):535-544
pubmed: 36250651
Am J Health Syst Pharm. 2022 May 6;79(10):730-735
pubmed: 35072701
Sci Rep. 2022 May 19;12(1):8424
pubmed: 35589787
Int J Appl Basic Med Res. 2019 Jul-Sep;9(3):135-142
pubmed: 31392175
J Oncol Pharm Pract. 2023 Jan 31;:10781552231153625
pubmed: 36718981
J Prim Care Community Health. 2018 Jan-Dec;9:2150131917747186
pubmed: 29357748
Int J Prev Med. 2018 Jan 29;9:7
pubmed: 29441184
Postgrad Med J. 2021 Mar;97(1145):168-174
pubmed: 32843483
J Am Pharm Assoc (2003). 2019 May - Jun;59(3):310-318
pubmed: 30940516
Pharmacy (Basel). 2022 Apr 22;10(3):
pubmed: 35645328
Sci Rep. 2022 Apr 26;12(1):6812
pubmed: 35473954